Sign In
TLIS.US
id: 1330

Talis Biomedical (TLIS) Investor Settlement

It is still possible to file a late claim. The court will decide whether to accept late claims or not.
N.D. California
Court
3:22-cv-00105
Case number
11 Feb 2021
Class period Start
11 Aug 2021
Class period End
21 Aug 2024
Claim deadline
Talis Biomedical reached a settlement with $TLIS investors to resolve claims that it misled them about delays in approval and launch of the Talis One COVID-19 test.
Case Status
Accepting Late Claims
Alleged Offence
Mismanagement
Misleading Statements
Omissions
Suspected Party
Directors
Management
Research Entity
Security Type
Stocks
Trade Direction
Long
Payout per Share
2.05
Filing date
13 January 2023
Plaintiffs
John Modrak
Attorneys
Bleichmar Fonti & Auld LLP (New York, NY), Pomerantz LLP (Los Angeles, CA), The Schall Law Firm (Los Angeles, CA)
Defendants
Brian Coe, J. Roger Moody, Jr., Felix Baker
Judge
Hon. Susan Illston
Administrator
A.B. Data Ltd
Exclusion deadline
20 August 2024
Attorney fee
$10,900,000
Class wide damages
$201,390,300
Trades matching type
FIFO
+$32,500,000
Cash Settlement Amount

Frequently Asked Questions